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Abstract.  A  number of cytoskeletal-associated pro- 
teins that are concentrated in focal contacts, namely 
ot-actinin,  vinculin,  talin,  and integrin,  have been 
shown to interact in vitro such that they suggest a 
potential link between actin filaments and the mem- 
brane.  Because some of these interactions are of low 
affinity,  we suspect that additional linkages also exist. 
Therefore,  we have used a  synthetic peptide corre- 
sponding to the cytoplasmic domain of/3~ integrin and 
affinity chromatography to identify additional integrin- 
binding proteins.  Here we report our finding of an 
interaction between the cytoplasmic domain of/3~ inte- 
grin and the actin-binding protein ot-actinin.  /3~-in- 
tegrin cytoplasmic domain peptide columns bound sev- 
eral proteins from Triton extracts of chicken embryo 
fibroblasts. One protein at ~100 kD was identified by 
immunoblot analysis as t~-actinin.  Solid phase binding 
assays indicated that ot-actinin  bound specifically and 
directly to the/3~  peptide with relatively high affinity. 
Using purified heterodimeric chicken smooth muscle 
integrin  (a/3t integrin)  or the platelet integrin glyco- 
protein l/b/RIa complex (a/33  integrin),  binding of 
a-actinin was also observed in similar solid phase as- 
says, albeit with a lower affinity than was seen using 
the/3~  peptide,  ot-Actinin  also bound specifically to 
phospholipid vesicles into which glycoprotein IIb/IIIa 
had been incorporated.  These results lead us to sug- 
gest that this integrin-t~-actinin  linkage may contribute 
to the attachment of actin filaments to the membrane 
in certain locations. 
I 
N many cell types, the adhesion of the cell to the extracel- 
lular  matrix  (ECM) ~ and the attachment  of the actin 
cytoskeleton to the cell membrane are both mediated 
through transmembrane proteins that act as receptors for the 
ECM. These proteins,  known as integrins,  are heterodimers 
composed of ot and/3  subunits,  many of which have been 
cloned and  sequenced (Buck and  Horwitz,  1987; Hynes, 
1987; Ruoslahti and Pierschbacher,  1987). Based on integrin 
sequence data, the ~ subunits from diverse cell types can be 
divided into at least five groups (/31,/~2, /~3, ~4,  /35).  These 
/3 chains  are very similar  to one another as well as being 
highly  conserved among  different  species.  The integrin  ot 
chains  are more variable,  however,  so that  ECM-binding 
diversity can be generated  through the association of differ- 
ent u  subunits  with a common/3 subunit. 
One integrin that has been especially well-characterized  is 
the  fibronectin  receptor  (~5/~0.  The  /31  subunit  of this 
fibronectin  receptor is shared  by the receptors for laminin 
(Gehlsen et al., 1988; Sonnenberg et al., 1988; Ignatius and 
Reichart,  1988) and collagen (Kunicki et al., 1988; Wayner 
et al.,  1988),  but the ot chain  is unique to the fibronectin 
receptor.  As with all  integrins,  each fibronectin  receptor 
subunit possesses a large extracellular  domain, a short trans- 
1. Abbreviations  used in this paper: CEF, chick embryo fibroblast;  ECM, 
extracellular matrix; GP llb/HIa, glycoprotein  IIb/IHa; WGA, wheat germ 
agglutinin. 
membrane segment, and a short cytoplasmic domain. Much 
attention has been focused on the extracellular  domains and 
on their binding to the ECM, which has been characterized 
in some detail.  Although  the cytoplasmic segments of the 
integrin  subunits  are known to be highly conserved, rela- 
tively little is known about the role of the integrin cytoplas- 
mic domains in attaching  actin to the cell membrane. One 
such site of attachment for actin filaments to the membrane 
occurs at focal contacts, which are sites of adhesion with the 
ECM. 
Much of our current understanding  of how microfilaments 
attach to focal contacts has been derived from in vitro bind- 
ing studies of purified proteins.  These studies have suggested 
a possible interaction  between ot-actinin,  an actin-binding 
protein,  and vinculin  (Wachsstock  et al.,  1987).  Vinculin 
has been shown to bind talin (Otto,  1983;  Wilkins  et al., 
1983; Burridge and Mangeat,  1984) and an interaction  be- 
tween talin and integrin  has also been demonstrated (Hor- 
witz et al., 1986), forming a potential protein-protein chain 
from the microfilament  bundles to the membrane. These in- 
teractions have provided the basis for a working model of fo- 
cal contact structure;  however, at least two of these associa- 
tions are of low affinity, suggesting that other proteins may 
be involved in stabilizing  this complex in vivo, or that other 
linkages  between actin and the membrane may exist (Bur- 
ridge et al.,  1988). 
We are interested  in identifying  cytoplasmic proteins that 
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membrane. To this end, we have made use of published inte- 
grin sequences to produce a synthetic peptide corresponding 
to the cytoplasmic  domain of the Bl  integrin subunit (Ar- 
graves et al.,  1987; Tamkun et al.,  1986). This peptide was 
used in affinity chromatography experiments to identify cy- 
toplasmic fibroblast proteins that bind to integrin.  Here, we 
report an in vitro interaction between the B~ integrin cyto- 
plasmic  domain and tx-actinin,  a  widely  distributed actin- 
binding protein. 
Materials and Methods 
Cell Culture 
Primary chick embryo fibroblast (CEF) cultures were prepared by trypsini- 
zation of skin from 8-10-d-old embryos. Cells were grown in DME (Gibco 
Laboratories,  Grand Island,  NY)  supplemented with  10%  FCS  (Gibco 
Laboratories), 50 U/ml penicillin, and 50 U/ml streptomycin. For experi- 
ments using  35S-iabeled  cells,  the  fibroblasts were grown overnight in 
methionine-free MEM (Gibco Laboratories) supplemented with 10 % FCS 
and 10%  DME containing 1 mCi 3SS-methionine  (ICN Biomedicals Inc., 
Costa Mesa, CA). 
Affinity Chromatography 
A  peptide Corresponding to residues 752-798  of the El  integrin subunit 
(Tamkun et al., 1986; Atgraves et al., 1987) x~ras synthesized for us by the Pro- 
tein Chemistry Facility of University of North Carolina at Chapel Hill-Na- 
tional Institute of Environmental Health and Safety (University of North 
Carolina,  Chapel Hill,  NC),  with the sequence NH2-Cys-Lys-Leu-Leu- 
Met-Ile-Ile-His-Asp-Arg-Arg-Glu-Phe-Ala-Lys-Phe-Glu-Lys-Glu-Lys- 
Met-Asn-Ala-Ly  s-Trp-Asp-Thr-Gly-Glu-Asn-Pro-Ile-Tyr-Lys-Ser-Ala- 
Val-Thr-Thr-Val-Vai-Asn-Pro-Lys-Tyr-Glu-Gly-Lys-COOH.  An  additional 
NH2-terminal  cysteine (not part of the sequence of B1 integrin)  was included 
in the synthetic peptide for use in coupling with an appropriate orientation. 
Although it has not been resolved whether the site of exit from the mem- 
brane is at the lysine (752)  or the histidine (758), we chose to use this 47 
amino acid peptide to represent the cytoplasmic domain of Bl integrin. The 
B1 cytoplasmic domain peptide was purified using reverse-phase HPLC, and 
subjected to amino acid analysis and partial sequence analysis to confirm 
that it contained the correct sequence. Purified peptide was coupled to 
thiopropyl sepharose 6B (Pharmacia Fine Chemicals, Piscataway,  NJ) at a 
concentration of 6 mg peptide per ml of resin. 
Cultured CEFs were extracted in 5 ml of 1%  Triton X-100  in column 
wash buffer (50 mM Tris acetate, 50 mM NaCI,  10 mM EGTA, and 2 mM 
MgCI2, pH 7.6) containing 125 #g/ml aprotinln and leupeptin, and the ex- 
tract was centrifuged at  100,000  g  at 4"C for I  h. The CEF extract was 
preabsorbed on a sepharose 6B column, then mixed with the peptide affinity 
resin for 20 min at 4°C, washed batcbwise five times with 10 vol of wash 
buffer, and eluted three times with 2 vol of 300 mM NaCI in wash buffer. 
Immunoblot Analysis 
Eluates from the peptide affinity column were dialyzed in 50 mM ammo- 
nium bicarbonate to remove salt, lyophilized, resuspended in sample buffer, 
and electrophoresed on 10% polyacrylamide gels according to the method 
of Laemmli (1970),  except that the bisacrylamide concentration was 0.13 %. 
Fractions from the integrin purification on wheat germ agglutinin-sepharose 
(WGA-sepharose) were electrophoresed  without prior dialysis. Immunoblot 
analysis was performed as described by Towbin et al.  (t979) with a  few 
modifications. Proteins were transferred from the gel to nitrocellulose, the 
nitrocellulose was incubated for 1 h in blocking buffer (2.5% BSA, 0.2% 
gelatin, and 0.05 % Tween 20 in TBS) and then cut into strips and incubated 
for 1 h in primary antibodies diluted 1:500 in blocking buffer. After washing 
for 1 h in washing buffer (0.2% gelatin, 0.05% Tween 20 in TBS), the strips 
were incubated for 1 h in second antibody (12SI-goat antirabbit for the pep- 
tide affinity column eluates and HRP-goat antirabbit for the WGA-sepharose 
column eluates), and washed again for 1 h. 12~I-labeled blots were mounted 
on cardboard and exposed to Kodak X-Omat film for 2-4 d, and peroxidase- 
labeled blots were reacted with 0.5 mg/ml 4-chloro-l-naphthol. 
Antibodies to myosin, talin, vinculin, filamin, tropomyosin, and ct-ac- 
tinin were prepared in the lab and were characterized previously. Antivi- 
mentin was obtained from Sigma Chemical Co. (St. Louis, MO). Antitubu- 
lin was the generous gift of Dr. Ted Salmon (University of North Carolina, 
Chapel Hill, NC) and antifibulin was the generous gift of Dr. Scott Argraves 
(American Red Cross, Rockville, MD). 
Protein Purification and Iodination 
Purification of vinculin and ct-actinin from chicken gizzard was performed 
as previously described (Feramisco and Burridge, 1980), with an additional 
purification by Mono Q column chromatography. Tropomyosin was purified 
from a 50-75 % ammonium sulfate fraction of a gizzard extract prepared as 
in the vinculin and a-actinin purification. This fraction was dialyzed into 
buffer B (20 mM Tris acetate, 20 mM NaC1, 0.1 mM EDTA, 0.1%/~-mer- 
captoethanol, pH 7.6) and subjected to anion exchange chromatography on 
DEAE-cellulose (DE52;  Whatman Inc., Clifton, NJ). Tropomyosin-con- 
raining fractions were pooled and  further purified on a  hydroxylapatite 
column.  Smooth muscle integrin was purified from chicken gizzard on 
WGA-sepharose as described previously (Kelly et al., 1987), except that the 
initial wash steps were performed with TBS (150 mM NaC1, 50 mM Tris- 
HC1, 0.1%  NAN3, pH 7.6) instead of water. Platelet glycoprotein IIb/IIIa 
was purified from human platelets as described by Parise and Phillips (1985). 
Purified  ct-actinln,  vinculin,  and  tropomyosin  were  labeled  with 
125iodine using the iodogen method. Iodogen (30/~1 of 5 mg/ml in CHC13; 
Pierce Chemical Co., Rockford, IL) was dried onto the inside of an eppen- 
doff  tube under a gentle nitrogen stream. Protein, in TBS, was added to the 
tube followed by 0.75 mCi of Na-t2sI (New England Nuclear, Wilmington, 
DE), and. the reaction was carried out at 4°C for 5 min. Saturated tyrosine 
solution was added to terminate the reaction. Labeled protein was separated 
from free iodine and iodo-tyrosine by chromatography on sephadex G-50 
in buffer B plus 0.2%  gelatin as carder.  The proteins were labeled to a 
specific activity of 1 x  107 cpm//~g for a-actinin, 5  x  106 cpm//zg for vin- 
culin, and 3  x  106 cpm/#g for tropemyosin. 
Solid Phase Binding Assay 
Removable microtiter wells (Dynatech Laboratories, Inc., Alexandria, VA) 
were coated with 50 #1 of ~  cytoplasmic domain peptide (1 mg/ml in PBS) 
or with 50/~1 of purified integrin for 1 h at 37°C. The wells were rinsed 
briefly with wash buffer (0.1% BSA, 0.1%  NAN3, in PBS), blocked with 
2% BSA for 30 rain at 37°C, then washed again. Control wells were coated 
with 2 % BSA alone. Iodinated protein and unlabeled protein were added 
to the wells and diluted to a final volume of 100/zl with PBS. The wells 
were incubated for 1 h at 37°C, then washed briefly four times with wash 
buffer,  and allowed to dry. Individual wells were removed and counted in 
a tabletop gamma counter (LKB Instruments, Gaithersburg, MD). 
To assess the ability of actin-binding proteins tropomyosin and t~-actinin 
to bind to the B peptide in the presence of actin filaments, iodinated protein 
was preincubated with polymerized rabbit skeletal muscle actin in 0.2 mM 
ATE 0.05 mM CaCI2,  2 mM Tris-HC1,  100 mM KCI, pH 8, for 90 rain 
at 37°C before their use in peptide binding assays. In this case, the level 
of protein binding in the absence of F-actin was determined using the same 
buffer,  except without F-actin. Background binding of t2sI-ot-actinln  and 
t2sI-tropomyosin to BSA-coated wells, also in the absence of F-actin, was 
subtracted from total counts bound and,  in all cases, was <2%  of total 
counts added. 
Proteolytic Cleavage of ~-Actinin 
t~-Actinin was dialyzed into 40 mM ammonium acetate (pH 8) containing 
1 mM CaC12, then digested with thermolysin (Sigma Chemical Co.) at a 
1:25 enzyme/~-actinln ratio for 2 h at 24°C with constant agitation. The 
cleavage products were fractionated on a Mono Q column equilibrated with 
buffer B (20 mM Tris acetate, 20 mM NaCI, 0.1 mM EDTA, 0.1% B-mer- 
captoethanol, pH 7.6) and eluted with a 0-400 mM NaC1 gradient in buffer B. 
Liposome Binding Assay 
Purified glycoprotein IIb/IIIa (GP IIb/IIIa) was incorporated into synthetic 
liposomes by the procedure of Parise and Phillips (1985).  Briefly,  Triton 
X-100 was removed from the purified GP IIb/IIIa by adsorption of the GP 
Ilb/IIIa onto a Con A affinity  column. The column was washed with Tris 
buffer containing octyl glucoside (50 mM Tris-HC1,  2 mM CaClz, 0.1 M 
NaCI, 60 mM octyl glucoside, and 0.02%  NAN3, pH 7.3),  and GP I~/IIIa 
was eluted with ot-methylmannoside (100 mM in the "Iris wash buffer). The 
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side, and applied to a Sephadex G-75 column to ~rnove contaminating Con A. 
To  make  the  liposomes,  phosphatidylserine and  phosphatidylcholine 
(Avanti Polar Lipids, Inc., Birmingham, AL) were mixed in a 70:30 ratio 
and dried under nitrogen to the sides of a glass test tube. GP ITo/IHa (with 
a trace mount of 13q-GP IIb/IIIa) was mixed with the phospholipids at a 
protein/phospholipid  ratio of 1:2.9, wt/wt. Octyl glucoside was removed by 
dialysis against Tris buffer (50 mM Tris-HCl, 3 mM CaCI2,  0.1  M NaC1, 
0.02%  NAN3, pH 7.3),  and the phospholipid vesicles were isolated by cen- 
trifugation. 
For the binding assay,  50 ttl of 125I-ct-actinin, 50 t~l of vesicles (either 
with or without incorporated GP IIb/IIIa), 50/zl of competitor (either ~1 
peptide, unlabeled a-actinin, or liposome buffer), and 50 t~l of liposome 
buffer (50 mM Tris-HC1,  6  mM CaCI2,  0.1  M  NaCI, 0.02%  NAN3, 2% 
BSA, pH 7.3) were incubated in an eppendorf  tube at room temperature for 
1 h, with occasional mixing. The liposomes were collected on filters and 
veashed two times with 1 ml of the Tris dialysis buffer, and the amount of 
bound 125I-ct-actinin was determined in a gamma counter. 
Results 
A synthetic peptide corresponding to the complete, 47 amino 
acid cytoplasmic domain of the integrin/31 subunit was syn- 
thesized and purified by HPLC. NH2-terminal cysteine was 
included in the sequence to facilitate coupling to the column 
matrix,  thiopropyl  sepharose  6B,  a  resin  which  allows 
specific coupling through SH groups.  Thus, the/31  peptide 
was bound through the terminal cysteine and maintained an 
orientation similar to that of the native protein at the cyto- 
plasmic face of the membrane. This affinity matrix was used 
to isolate integrin-binding proteins from Triton X-100 ex- 
tracts of 35S-methionine-labeled cultured CEFs.  As  shown 
in Fig. 1, elution with 300 mM salt revealed a number of  pro- 
teins retained by the peptide affinity resin. 
To determine if any of these bands  represented known 
cytoskeletal proteins,  samples  of the  column eluate were 
analyzed by immunoblotting with a panel of specific antibod- 
ies. Antibodies to fibulin, filamin, myosin, talin, vimentin, 
tropomyosin, and tubulin failed to react with proteins eluted 
from the peptide column (data not shown). As seen in Fig. 
Figure I. SDS-PAGE  analysis 
of  affinity  chromatography 
with the integrin cytoplasmic 
domain peptide. The/31 pep- 
tide was conjugated  to thiopro- 
pyl sepharose 6B. An extract 
of 35S-labeled CEFs (lane 1) 
was centrifuged  to remove  par- 
ticulates, and the supernatant 
(lane  2)  was  applied  to  the 
peptide column. Flowthrough 
(lane  3)  was  collected  and 
the column was washed exten- 
sively  (wash, lane  4),  then 
eluted with 300 mM salt (elu- 
ate, lane 5). The positions of 
molecular mass standards are 
shown at left in kilodaltons. 
Figure 2.  Immunoblot analysis of/3~-column eluate.  ~25I-labeled 
molecular  weight standards  were loaded in lane  1 of each  set. 
Whole CEF extract was loaded in lane 2.  /3t-column eluate was 
loaded in lane 3. The gel was blotted onto nitrocellulose and stained 
with antibodies to t~-actinin, vinculin, and talin, followed by 1251- 
goat antirabbit. Note that talin is not detected in the column eluate, 
unlike vinculin and tx-actinin. 
2,  only antibodies to ot-actinin and vinculin reacted posi- 
tively in the immunoblot assays. 
We wanted to know if t~-actinin,  vinculin, or both were 
capable of binding directly to the 131 cytoplasmic domain, 
and we addressed this question using a solid phase protein 
binding assay.  For these experiments, microtiter wells were 
coated with the/3~  peptide, and the binding of 125I-labeled 
protein was measured by competitive inhibition in the pres- 
ence of increasing concentrations of unlabeled protein. In 
this assay,  no significant binding of 125I-vinculin to the inte- 
grin peptide was detected (Fig. 3 A), suggesting that vinculin 
may bind to the peptide affinity column through an associa- 
tion  with  some  other  integrin-binding  protein.  However, 
significant binding  of 12sI-tx-actinin to the  131  cytoplasmic 
domain was observed, and this binding was inhibited by the 
addition of excess unlabeled a-actinin (Fig. 3 B). Scatchard 
analysis of these data demonstrated an apparent KD of 1.6 
×  10-SM (Fig.  3  C). 
Using  the  solid  phase  binding  assay,  we  characterized 
more fully the specificity of ot-actinin  binding to the/3~ cy- 
toplasmic domain.  In  these experiments,  we asked  if un- 
related proteins (both globular and rod-shaped) could com- 
pete with u-actinin for binding to the integrin peptide. As 
shown in Fig. 4, the binding of <x-actinin to/31 peptide was 
inhibited by the addition of increasing concentrations of un- 
labeled  ot-actinin  or  free  /31  peptide,  but  not  by  several 
other proteins, including BSA, ovalbumin, talin, or vinculin. 
Surprisingly, binding of u-actinin to/31 peptide was also in- 
hibited  by  tropomyosin  (Fig.  4),  and  we  found  that  1251- 
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Figure 3. Binding of vinculin and ~x-actinin to ~/~ integrin cytoplas- 
mic domain peptide.  (A) Binding of 125I-vinculin to wells coated 
with  Bl  cytoplasmic  domain  (closed squares) or  BSA  (open 
squares) in the presence of excess unlabeled vinculin. (B) Binding 
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Figure 4.  Specificity of a-actinin binding to the/~  integrin cyto- 
plasmic domain peptide. Binding of z2SI-ot-actinin to/~t peptide in 
the presence of increasing concentrations of free/3 peptide (open 
triangle); ol-actinin (solid triangle); BSA (solid circle); ovalbumin 
(open diamond); talin (solid diamond); vinculin (solid square); or 
tropomyosin (open square). Specific activity of ot-actinin  was the 
same as in Fig. 4, and 6  x  104 cpm were added to each well. 
tropomyosin  bound  to  /~  peptide  in  a  solid  phase  assay 
(data not shown).  Tropomyosin contains a  large amount of 
a-helix  arranged  in  a  coiled  coil  structure  (Cohen  and 
Holmes,  1963).  a-Actinin is a protein with a high ¢x-helical 
content (Suzuki et al.,  1976), some of which may also be ar- 
ranged in a coiled coil structure.  This raises the possibility 
that the/$~  peptide may be binding  specifically to a  coiled 
coil conformation.  To test this, we isolated the light mero- 
myosin fragment of myosin which  is composed  largely of 
coiled coil o~-helices (Lowey and Cohen,  1962),  and  used 
this as a competitor in the solid phase binding assay. How- 
ever,  the  solubility  requirements  of light  meromyosin  de- 
mand a high ionic strength buffer, and this buffer inhibited 
the binding of a-actinin to the/3 peptide in the solid phase 
assay, so that we were unable to obtain interpretable results 
for the binding of light meromyosin to the B peptide. Further 
experiments  will  be aimed  at testing  the  affinity of the  B~ 
peptide for other proteins  with a  coiled coil structure. 
Since  tropomyosin  binds  to the  isolated  Bt  cytoplasmic 
domain peptide,  we were surprised that it was not detected 
eluting from the peptide affinity colunm.  One possibility is 
that the peptide-binding  site on tropomyosin is obscured by 
binding  to  actin  filaments.  We  found  that  the  binding  of 
tropomyosin to the peptide was inhibited by very low actin 
concentrations (Fig.  5). At equivalent concentrations of ac- 
of ~25I-c~-actinin to wells coated with B~ cytoplasmic domain pep- 
tide (squares) or BSA (diamonds) in the presence of excess c~-ac- 
tinin.  All points represent the average of duplicate experiments. 
t25I-c~-actinin did not bind to wells coated with a control, unrelated 
peptide (data not shown).  (C) Scatcbard plot analysis of c~-actinin 
binding to Bt peptide.  The iodinated proteins were labeled with 
specific activities of 1  ×  107 cpm/#g for ~-actinin and 5  x  10  6 
cpm/#g for vinculin. In each assay, 12 ng of ~2SI-vinculin and 6 ng 
of ~2sI-ot-actinin were used,  so that 6  ×  10  4 cpm were added to 
each well. 
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Figure 5. Effect of filamentous actin on the binding of tropomyosin 
and c~-actinin to/~ integrin.  ~25I-labeled  protein was preincubated 
with varying concentrations of F-actin for 90 min, and this mixture 
was then added to wells coated with/~ cytoplasmic domain peptide. 
t2~I-<x-actinin (diamonds);  l~I-tropomyosin  (circles).  AU  points 
represent  the  average  of duplicate  experiments.  Binding  is  ex- 
pressed as a percentage  of ~25I-protein  bound to the/~-peptide in 
the absence of F-actin. 6 ng of c~-actinin (at 1 x  104 cpm/ng) and 
20 ng of tropomyosin (at 3  ×  103 cpm/ng) were added in each as- 
say. Maximal tropomyosin bound (100%) was 2.2  x  10  ~ cpm, or 
38% of total counts added.  Maximal a-actinin bound was 2.9  x 
10  ~ cpm, or 48%  of total counts added. 
tin, oz-actinin binding to the peptide was much less affected, 
although  this too was inhibited  at higher actin concentra- 
tions.  This inhibition  of ~-actinin binding  may be due  to 
crosslinking of actin filaments preventing access of o~-actinin 
to the peptide in this assay. 
We next wanted to determine which domain of the oc-ac- 
tinin molecule was responsible for binding to integrin. To ad- 
dress this question, we generated the two major proteolytic 
fragments of ot-actinin that can be obtained by cleavage with 
thermolysin, as has been described previously (Mimura and 
Asano, 1987). Thermolysin digestion yields a 27-kD globu- 
lar fragment, which contains the actin-binding domain, and 
a  53-kD rod-like fragment,  which contains  four repeating 
units that may be involved in dimerization. These two ot-ac- 
tinin fragments were purified by FPLC (Fig. 6 A). Solid phase 
binding assays were carried out to determine which fragment 
could compete with 125I-~-actinin for binding to the I~1 cyto- 
plasmic domain. As shown in Fig. 6 B, binding of t25I-u-ac- 
tinin to the B~ peptide was inhibited by the 53-kD fragment, 
but not by the 27-kD actin-binding fragment. These results 
indicate that the integrin-binding  site is located within the 
domain of oe-actinin  that lacks the actin-binding site. 
We extended these findings by asking if o~-actinin could 
bind to intact heterodimeric integrin,  as well as to the syn- 
thetic ~t cytoplasmic domain peptide.  Also, we wanted to 
know if integrins  containing  I~ chains  other than #~  were 
capable of binding to ot-actinin. To address these questions, 
we used two different integrins: the chicken smooth muscle 
integrin and the platelet GP IIb/ffla. Smooth muscle integrin 
has not been sequenced yet, but it has been shown to cross 
react with  a  polyclonal antibody  specific for the  ~  cyto- 
plasmic domain (Marcantonio  and  Hynes,  1988)  and has 
therefore been classified as a  t3~ integrin (C.  Otey, unpub- 
lished observation). The platelet GP llb/l-l/a has been classi- 
fied as a/if3 integrin based on sequence data. These two inte- 
grins were purified from chicken gizzard and human platelets, 
respectively, (Fig. 7 A), adsorbed to microtiter wells, and al- 
lowed to bind to  ~25I-ot-actinin either alone or in the pres- 
ence of an excess of unlabeled ot-actinin. Very similar results 
were  obtained  with  both purified  integrins:  ~2sI-a-actinin 
Figure 6. Binding of c~-actinin 
fragments  to  the  integrin  /31 
cytoplasmic  domain peptide. 
(A)  Coomassie  blue-stained 
SDS-polyacrylamide gel. (lane 
1) Molecular weight standards; 
(lane 2) intact c~-actinin, over- 
loaded to demonstrate purity; 
(lane 3) products of thermoly- 
sin cleavage. Positions of ther- 
molysin  (arrow) and the two 
major c~-actinin fragments (ar- 
rowheads) are labeled.  (lane 
4)  Purified  27-kD  u-actinin 
fragment; (lane 5) purified 53- 
kD  ~-actinin  fragment.  (B) 
Binding inhibition assay.  Wells 
were coated with l~t cytoplas- 
mic  domain  peptide.  Intact 
~I-c=-actinin was added to the 
wells in the presence of increas- 
ing  concentrations  of  intact 
c=-actinin (diamonds), the 27- 
kD fragment (squares), or the 
53-kD fragment (circles) of u-actinin.  The concentrations of 27- and 53-kD fragments were estimated by comparison with BSA standards 
on SDS gels. The specific activity, total counts added, and concentration of l~I-¢x-actinin was approximately the same as in Fig. 4. Bind- 
ing is expressed as a percentage  of maximal 125I-u-actinin  bound to the 1~1 peptide in the absence of any inhibitor. 
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Figure 8.  Binding of 125I-~-actinin  to synthetic phospholipid  vesi- 
cles. Vesicles were prepared either with GP IIb/IIIa (solid bar) or 
without  incorporated protein (hatched bar),  and were  incubated 
with  125I-u-actinin alone or  with excess  unlabeled u-actinin (3 
mg/ml) or cytoplasmic domain peptide (10 mg/ml) as competitors. 
Values were normalized with respect  to  ~3tI-labeled GP IIb/IIIa, 
which was incorporated in trace  amounts to monitor the relative 
number of vesicles  used in each experiment. (GP vesc)  vesicles 
containing GP IIb/IIIa; (Pvesc) plain vesicles;  (a-A) u-actinin. 
bound to each integrin and was displaced by unlabeled c~-ac- 
tinin (Fig. 7, B and C). When these binding data were sub- 
mitted to Scatchard plot analysis, an apparent KD of 2.5  X 
10  -6 was obtained for binding of a-actinin to smooth mus- 
cle integrin and 2.1  ×  10  -6 for binding to GP IIb/IIIa. 
These results indicate that ct-actinin can bind to intact inte- 
grin adsorbed to the surface ofa microtiter well, but because 
integrins in the cell exist in a lipid bilayer, we wanted to de- 
termine if a-actinin could interact with integrin in a mem- 
brane environment. Other labs have demonstrated the use- 
fulness of incorporating purified integrin into phospholipid 
vesicles to measure binding of ligands to the extracellular 
domain of integrin, and this system has been used most suc- 
cessfully with GP IIb/IIIa (Parise and Phillips,  1985,  1986). 
It has been reported previously that with large phospholipid 
vesicles, 55 % of the GP IIb/IIIa molecules are oriented with 
their  extracellular domains  on  the  outside  of the  vesicle 
(Parise and Phillips,  1985),  suggesting that the remaining 
45%  are oriented "inside out," with their cytoplasmic do- 
mains exposed. Thus, these synthetic vesicles could also be 
used to measure binding of ligands to the cytoplasmic do- 
main of integrin. 
Figure 7. Binding of u-actinin  to purified intact integrins. (A) Coo- 
massie blue-stained SDS-polyacrylamide  gel.  (lane 1) Molecular 
weight  standards;  (lane 2)  smooth  muscle integrin (~1) purified 
from chicken gizzard;  (lane 3) glycoprotein  IIb/IIIa (~3) purified 
from human platelets. (B) Binding of 125I-a-actinin  to wells coated 
with smooth muscle integrin. Maximal binding represents 8 ×  10  3 
cpm, of the 6  ×  10  4 cpm added per assay. (C) Binding of I25I-a- 
actinin  to wells coated with glycoprotein IIb/IIIa. Maximal binding 
represents  g ×  10  3 cpm, of the 6  x  104 cpm added per assay. (in- 
set graphs)  Scatchard plot analysis of u-actinin  binding to smooth 
muscle integrin (B) or GP IIb/IIIa (C). 
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prepared either with or without incorporated GP IIb/IIIa. To 
measure the specific binding of u-actinin to the GP lib/IIIa, 
plain vesicles or GP IIb/IIIa vesicles were incubated with 
~2~I-a-actinin together with unlabeled a-actinin, free/3 pep- 
tide, or buffer alone.  The vesicles were then collected on 
filters, washed, and counted in a gamma counter. As shown 
in Fig. 8, significant binding of ~25I-~-actinin to GP fib/Ilia 
vesicles, but not plain vesicles, was detected. This binding 
was competitively displaced by the addition of either excess 
a-actinin or B peptide, suggesting that the binding of oL-ac- 
tinin to GP lib/Ilia is specific for the cytoplasmic domain of 
the integrin. 
If ot-actinin does interact directly with integrin, as these 
in vitro experiments suggest, one might expect ct-actinin to 
associate with the integrin heterodimer through the initial 
steps of its isolation. To address this question, smooth mus- 
cle integrin from chicken gizzard was eluted from a WGA- 
Sepharose column (Fig. 9 A), and integrin-containing frac- 
tions  were  then analyzed by immunoblot to determine if 
a-actinin was also present. As shown in Fig. 9 B, a-actinin 
was detected eluting from the column together with integrin. 
Although this is consistent with an in vivo interaction between 
et-actinin and integrin, a direct interaction between c~-actinin 
and integrin is not conclusively demonstrated because the 
column eluate also contained actin, as well as several other 
proteins. 
Discussion 
In this report, we describe a specific, high-affinity interac- 
tion between o~-actinin and the cytoplasmic domain of the 
/3~ integrin subunit. At the outset of this work, we did not 
anticipate finding an interaction between a-actinin and inte- 
grin.  Since its discovery in nonmuscle cells, a-actinin has 
been suggested on several occasions to be a potential link be- 
tween actin filaments and cell membranes. The popularity of 
this idea has vacillated. Originally, ot-actinin was noted in fo- 
cal contacts at the ends of stress fibers and this led to the idea 
that it might be involved in anchoring these structures (I.ara- 
rides and Burridge, 1975).  Then it was shown that o~-actinin 
Figure 9.  Detection of ct-ac- 
tinin  with  partially  purified 
smooth muscle integrin.  (,4) 
Coomassie blue-stained SDS- 
polyacrylamide gel. A Triton 
X-100 extract of chicken giz- 
zard (lane 1)  was applied to 
a  WGA-sepharose  column, 
washed extensively  (wash  frac- 
tion, lane 2), and eluted with 
N-acetyl-glucosamine  (elu- 
ate,  lane  3).  (B)  Duplicate 
lanes were transferred to ni- 
trocellulose and stained with a 
polyclonal antibody to avian 
a-actinin followed by peroxi- 
dase-labeled second antibody, 
and reacted with 4-chloro-1- 
naphthol. 
could be extracted from isolated plasma membranes leaving 
much of the actin still associated with the membranes (Bur- 
ridge and McCullough, 1980).  However, these membranes 
were prepared from cells grown in suspension which would 
have lacked both stress fibers and focal contacts. Subsequent 
work using immunoelectron microscopy suggested that o~-ac- 
tinin is located farther from the membrane than vinculin or 
talin (Chen and Singer,  1982).  The role of ~-actinin in an- 
choring skeletal muscle myofibrils is also unclear. Although 
immunoelectron microscopy of chicken skeletal muscle sug- 
gested that oe-actinin may be absent from the myofibrillar ter- 
mini (Tidball, 1987),  genetic studies of insect flight muscle 
have shown that the sites of muscle insertion are disrupted 
in mutants lacking normal a-actinin (Fyrberg et al., 1990). 
In general, the view has evolved that ~-actinin may be lo- 
cated some distance from the membrane, and that it may be 
just one link in a chain of proteins involved in attachment of 
actin to the membrane (Burridge et al., 1988).  Our findings 
in this paper suggest a more direct role for ct-actinin, and that 
ct-actinin may form a bridge between actin and the cytoplas- 
mic domain of integrin in some circumstances. 
Our results differ from those of an earlier study which 
demonstrated that talin, and not a-actinin, bound to integrin 
in an equilibrium gel filtration assay (Horwitz et al., 1986). 
Our lack of detection of talin binding in the current assays 
is consistent with the low affinity for the talin-integrin inter- 
action previously noted. That binding of  c~-actinin to integrin 
was not detected in the former work is perhaps surprising, 
but may have been due to the harsh conditions used to elute 
the integrin from the immunoaffinity  column. Alternatively, 
the ct-actinin-integrin complex may have not generated a 
sufficient shift in Stokes' radius to be detected in that assay. 
In our current study, we initially detected binding of tx-ac- 
tinin to a synthetic peptide that corresponds to the cytoplas- 
mic domain of the integrin/~t polypeptide, and then verified 
our results with two purified integrins. We found that tx-ac- 
tinin interacts with the integrin B-chain cytoplasmic domain 
under three distinct sets of conditions. First, tx-actinin from 
a whole cell detergent extract bound to the synthetic peptide 
immobilized to an affinity matrix. Second, purified chicken 
gizzard o~-actinin bound both to the peptide and to purified 
heterodimeric integrin from two sources,  chicken gizzard 
and human platelets (GP IIb/IIIa). Third, purified a-actinin 
bound to glycoprotein IIb/IIIa which had been incorporated 
into phospholipid vesicles, indicating that binding does oc- 
cur when integrin is in a membrane environment. 
The results of our solid phase binding assays indicate that 
c~-actinin binds with lO0-fold higher affinity to the/31  syn- 
thetic peptide than to purified heterodimeric integrin. It is 
possible that the presence of  the ~x subunit in the integrin het- 
erodimer exerts  some regulatory effect on the binding of 
a-actinin to the ~ subunit, such that the affinity of ot-actinin 
for intact integrin is reduced. Alternatively, the reduced affin- 
ity could result from the cytoplasmic domain of the intact 
integrin adopting a less favorable conformation than the free 
peptide adsorbed to microtiter wells. The experiments using 
purified integrins also demonstrated that a-actinin binds to 
integrins from both the B1 and/~3 subfamilies. The cytoplas- 
mic domains of these two B subunits are highly homologous, 
but not identical. We plan to investigate the possibility that 
ce-actinin may interact with integrins from other subfamilies 
as well. 
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Argraves et al. (1989), who also performed affinity chroma- 
tography experiments with a synthetic fll cytoplasmic do- 
main peptide. Using extracts of human placenta, Argraves 
and coworkers identified a single major 100-kD band which 
could be eluted from the/31  column with EDTA, and this 
protein was given the name fibulin. Sequence analysis and 
immunoblotting demonstrated that fibulin is clearly distinct 
from a-actinin. Argraves et al. (1989) did not detect tx-ac- 
tinin binding to their fl~ peptide columns, but the synthetic 
peptide used in their columns was 10 residues shorter than 
our peptide, and it is possible that these 10 residues may con- 
tribute to o~-actinin binding. Also, the detergents and ionic 
conditions used by Argraves et al.  (1989)  differed signifi- 
cantly from ours. In particular, Argraves et al. used calcium- 
containing buffers and were able to elute fibulin with EDTA, 
while we used EGTA-containing buffers throughout, which 
may explain the absence of fibulin in our column eluates. 
Our results may relate to a recent analysis of the sequence 
homology that ct-actinin shares with dystrophin, the protein 
absent  from patients  with Duchenne muscular dystrophy 
(Hammond,  1987; Koenig et  al.,  1988;  Davison  et  al., 
1989).  Dystrophin has been localized to the sarcolenuna of 
normal  skeletal  muscle  (Zubrzycka-Gaarn,  et  al.,  1988; 
Arahata et al., 1988; Watkins et al., 1988), and there is evi- 
dence to suggest that dystrophin may associate with a mem- 
brane glycoprotein in muscle (Campbell and Kahl,  1989). 
Dystrophin  shares  homology with  o~-actinin in  its  NH~- 
terminal actin-binding domain, in a COOH-terminal region, 
and in its multiple repeats of •110  amino acids (Hammond, 
1987; Koenig et al., 1988;  Davison et al., 1989).  Based on 
these  observations,  it  will  be  interesting  to  determine 
whether the integrin-binding site in ct-actinin is conserved in 
dystrophin and whether dystrophin interacts with integrin in 
the muscle sarcolemma. Possibly the lack of c~-actinin in ter- 
minal Z-discs and myotendinous junctions (TidbaU,  1987) 
reflects its replacement in these sites by dystrophin, which 
has been localized to the myotendinous junctions (Shimizu 
et al.,  1989). 
The eluted fractions from our peptide columns also con- 
tained a number of unidentified proteins which we are con- 
tinuing to characterize.  Some of these proteins may have 
bound to the affinity column through interactions with other 
integrin-binding proteins, as may be the case with vinculin. 
However,  it is possible that some of these uncharacterized 
proteins may bind to integrin directly and with high affinity. 
Currently, we are working to purify these unknown proteins 
in order to investigate their interactions with other focal con- 
tact proteins. 
Although our data suggest an interaction between integrin 
and ot-actinin,  it should be noted that most of these experi- 
ments were based on in vitro assays using purified proteins. 
We are now focusing on experiments designed to ask if ot-ac- 
tinin and integrin also interact in vivo.  This was addressed 
in a preliminary manner by asking if ot-actinin copurifies with 
the integrin heterodimer. Although a-actinin was detected in 
integrin-containing column fractions, these also contain ac- 
tin and some other proteins. Thus, the presence of c~-actinin 
in the integrin preparations cannot be taken as unambiguous 
evidence of a direct, physiological interaction between tx-ac- 
tinin and integrin. Further experiments are being aimed at 
resolving this issue. 
The evidence to date suggests that more than one type of 
linkage attaches the actin cytoskeleton to the focal contact: 
one may involve an integrin-talin association and another, 
identified here, may involve an interaction between integrin 
and ot-actinin. The discovery of a number of proteins, as yet 
uncharacterized,  that  are  localized  to  the  focal  contact 
(Beckerle, 1986; Glenney and Zokas, 1989; Wilkins et al., 
1986) suggests that additional linkages may also exist. These 
multiple linkages could reflect different stages in the matu- 
rity of a focal contact or Aifferent structural requirements. 
One of the challenges in this area of research will be to un- 
derstand how these multiple linkages are regulated as well 
as their roles in such diverse integrin functions as embryo- 
genesis, fibroblast motility, and platelet aggregation. 
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Note Added in Proof We have found that a synthetic peptide with a coiled 
coil conformation and two myosin fragments (long s-2 and short s-2) with 
high coiled coil content do not compete with c~-actinin  for binding to the 
B~ integrin peptide. 
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